Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 40 checked references that resolve
resolves10.1023/A:1016268311867Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects
resolves10.1016/0041-008X(78)90091-1Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides
resolves10.1016/S0024-3205(01)01511-9Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatin
resolves10.1002/hep.1840130502Hepatic fibrosis and cirrhosis after chronic administration of alcohol and “low-dose” carbon tetrachloride vapor in the rat
resolves10.1038/sj.jid.5700485Nanoemulsions as Versatile Formulations for Paclitaxel Delivery: Peroral and Dermal Delivery Studies in Rats
resolves10.1016/j.jcis.2007.06.087Improved solubilization of carbamazepine and structural transitions in nonionic microemulsions upon aqueous phase dilution
resolves10.1021/la7022874Ultrasound Mediates the Release of Curcumin from Microemulsions
resolves10.1023/A:1015868809990Protection Against Microcystin-LR-Induced Hepatotoxicity by Silymarin: Biochemistry, Histopathology, and Lethality
resolves10.1002/jat.2550100408Prevention by silymarin of membrane alterations in acute CCI<sub>4</sub> liver damage
resolves10.1002/jat.2550120613Silymarin protects against paracetamol‐induced lipid peroxidation and liver damage
resolves10.1007/s13181-010-0030-9Comparison of the Prophylactic Effect of Silymarin and Deferoxamine on Iron Overload-Induced Hepatotoxicity in Rat
resolves10.1016/j.addr.2007.10.010Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies
resolves10.1093/ajcp/28.1.56A Colorimetric Method for the Determination of Serum Glutamic Oxalacetic and Glutamic Pyruvic Transaminases
resolves10.1016/S0021-9258(19)38899-4The in vitro NADPH-dependent inhibition by CCl4 of the ATP-dependent calcium uptake of hepatic microsomes from male rats. Studies on the mechanism of the inactivation of the hepatic microsomal calcium pump by the CCl3.radical.
resolves10.1166/jnn.2006.440Improved Oral Delivery of Paclitaxel Following Administration in Nanoemulsion Formulations
resolves10.1055/s-2006-962757Silybin Dihemisuccinate Protects Rat Erythrocytes Against Phenylhydrazine-Induced Lipid Peroxidation and Hemolysis
resolves10.1016/j.ijpharm.2007.06.016Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations
resolves10.1007/BF02977782Formulation and biopharmaceutical evaluation of silymarin using SMEDDS
The 13 references without a DOI — listed, not checked
no DOI — not checkedBarbarino, F., Neumann, E., Deaciuc, I., Ghelberg, N. W., Suciu, A., Cotutiu, C., Racovitǎa, L., Stroilǎa, C., Nagy, S., Pǎarǎau, N., Toader, S., and Brilinschi, C., Effect of silymarin on experimental liver lesions. Med. Interne, 19, 347–357 (1981).
no DOI — not checkedDesplaces, A., Choppin, J., Vogel, G., and Trost, W., The effects of silymarin on experimental phalloidine poisoning. Arzneimittelforschung, 25, 89–96 (1975).
no DOI — not checkedGadetta, V., Bombardelli, E., and Pifferi, G., Complexes of flavanolignans with phospholipids, preparations thereof and associated pharmaceutical compositions. U. S. Patent, 4764508 (1988).
no DOI — not checkedGalighter, A. E. and Koyloff, E. N., Essential of Practical Microtechnique, Lea and Febiger, Philadelphia, (1971).
no DOI — not checkedKingsley, S. R. and Frankel, S. J., The determination of serum total protein albumin and globulin by the biuret reaction. J. Biol. Chem., 128, 131–137 (1939).
no DOI — not checkedMadaus, R., Halbach, G., and Trost, W., Salt of silymarin group with aminopolyhydroxy alcohols. U. S. Patent, 3994925 (1976).
no DOI — not checkedMorazzoni, P. and Bombardelli, E., Silybum marianum (Carduus marianus) Fitoterapia, 66, 3–42 (1994).
no DOI — not checkedPradhan, S. C. and Girish, C., Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J. Med. Res., 124, 491–504 (2006).
no DOI — not checkedRainone, F., Milk thistle. Am. Fam. Physician, 72, 1285–1288 (2005).
no DOI — not checkedSchriewer, H. and Weinhold, F., The influence of silybin from Silybum marianum (L.) Gaertn. on in vitro phosphatidyl choline biosynthesis in rat livers. Arzneimittelforschung, 29, 791–792 (1979).
no DOI — not checkedThakur, S. K., Silymarin-A hepatoprotective agent. Gastroenterol. Today, 6, 78–82 (2002).
no DOI — not checkedWachter, W. and Zaeske, H., Process for the manufacture of flavanolignan preparation with improve release and absorbability, compositions obtainable thereby and their use for the preparation of pharmaceuticals. U. S. Patent, 6020384 (2000).
no DOI — not checkedWang, M., Grange, L. L., and Tao, J., Hepatoprotective properties of Silybum marianum herbal formulation on ethanol-induced liver damage. Fitoterapia, 67, 167–171 (1996).
checked 2026-07-22 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.